CompanyOverview|NYSE:NVO] Despite a massively successful run as Chief Executive Officer (CEO) of pharma giant Novo Nordisk ...

Dana Simmons wants you to know that if you are hungry, it is not your fault. In her recently released book, “On Hunger: ...

GLP-1s are gaining interest for their impact on weight, blood sugar, and possibly mood in bipolar disorder. Here’s what ...

Omada is trading publicly after 14 years of providing support to patients with weight-related chronic illnesses. Leadership sees the current moment as the perfect time for an IPO, as GLP-1 drugs such ...

The mother-of-two was surprised to find out that she was pregnant with another child after struggling to conceive in the past ...

The next round of Medicare's historic drug price negotiations could save billions for seniors taking medications like Ozempic ...

Everything you need to know about how to ski Verbier on a budget. Writer Claire McAteer shares her travel tips ...

Dr. Shervin Naderi and his team integrate facial rejuvenation with weight loss care to manage the structural facial changes ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

US woman Caroline Davis shared incredible before and after images of her weight loss after using semaglutide drug Wegovy.